Rosa Vizcarra, MD
Geriatric Medicine · San Antonio, TXNPI 1649206087
Payments from drug & device makers
Across 408 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$1K
- AstraZeneca$1K
- Amgen$1K
- Lilly USA, LLC$697
- GSK$467
- plus $3K from 35 others
What the payments were for
- Food & beverage$9,303100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,726 |
| AbbVie | 58 | $1,353 |
| AstraZeneca | 32 | $1,248 |
| Amgen | 61 | $1,145 |
| Lilly USA, LLC | 33 | $697 |
| GSK | 23 | $467 |
| Bayer | 5 | $303 |
| Esperion Therapeutics, Inc. | 6 | $283 |
| Boehringer Ingelheim | 17 | $261 |
| Intuitive Surgical | 3 | $241 |
| Pfizer | 14 | $233 |
| Abbott | 5 | $195 |
| Corcept Therapeutics | 4 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $143 |
| Astellas Pharma US Inc | 5 | $84 |
| Johnson & Johnson | 4 | $75 |
| Tactile Systems Technology Inc | 2 | $70 |
| Amarin Pharma, Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| Angiodynamics, Inc. | 1 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 1 | $29 |
| Merck | 2 | $28 |
| Coloplast | 1 | $27 |
| Exact Sciences | 1 | $25 |
| Almatica Pharma LLC | 1 | $22 |
| Inari Medical, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Novartis | 1 | $12 |
| Dynavax Technologies Corporation | 2 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,303 in reported general payments places this provider in the 95th percentile of 275 geriatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 125 | $161,309 |
| JardianceEmpagliflozin | 91 | $117,684 |
| FarxigaDapagliflozin Propanediol | 102 | $100,580 |
| RybelsusSemaglutide | 40 | $55,414 |
| MounjaroTirzepatide | 48 | $53,409 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 147 | $46,929 |
| ProliaDenosumab | 20 | $34,753 |
| JanuviaSitagliptin Phosphate | 24 | $28,278 |
| TrulicityDulaglutide | 13 | $27,110 |
| EliquisApixaban | 36 | $21,624 |
| Breo ElliptaFluticasone/Vilanterol | 35 | $19,408 |
| Repatha SyringeEvolocumab | 15 | $15,989 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 56 | $12,487 |
| Xigduo XrDapaglifloz Propaned/Metformin | 21 | $12,322 |
| SynjardyEmpagliflozin/Metformin Hcl | 17 | $12,262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,726 | $216,723165 claims |
| Boehringer IngelheimJardiance, Synjardy | $261 | $129,945108 claims |
| AstraZenecaFarxiga, Nexium | $1,248 | $103,725114 claims |
| Lilly USA, LLCMounjaro, Trulicity | $697 | $80,51961 claims |
| PfizerAbrysvo, Eliquis | $233 | $68,553183 claims |
| GSKBreo Ellipta, Shingrix, Trelegy Ellipta | $467 | $42,313107 claims |
| AmgenProlia | $1,145 | $34,75320 claims |
| MerckJanuvia | $28 | $28,27824 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $84 | $16,27625 claims |
| AbbVieSynthroid | $1,353 | $3,25750 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 275 geriatric medicine providers in Texas.
Other geriatric medicine in San Antonio
- Gabriel Urrea-BoteroSan Antonio$3K
- David EspinoSan Antonio$3K
- Dean KelloggSan Antonio$3K
- Diana KerwinDallas$12.7M
- Mauricio Gonzalez-AriasAustin$825K
- Eberenne IgbokwePearland$124K
- Janice KneblFort Worth$54K
- David SmithBrownwood$19K
- Alejandro ArizmendiHelotes$15K
- George TaffetHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.